Mirvetuximab soravtansine (Elahere®) for the treatment of adults with folate receptor-alpha (FRα) positive epithelial ovarian, fallopian tube and primary peritoneal cancer

Rothschedl, E. and Malikova, E. and Grössmann, N. (2024): Mirvetuximab soravtansine (Elahere®) for the treatment of adults with folate receptor-alpha (FRα) positive epithelial ovarian, fallopian tube and primary peritoneal cancer. Fact Sheet Nr. 193.

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
193kB

Item Type:	Horizon Scanning of Medicines
Subjects:	QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology QZ Pathology > QZ 200-380 Neoplasms.Cysts WB Practice of medicine > WB 300-962 Therapeutics WI Digestive system > WI 900-970 Abdomen WP Gynaecology > WP 440-468 Uterine diseases
Language:	English
Series Name:	Fact Sheet Nr. 193
Deposited on:	18 Dec 2024 14:45
Last Modified:	18 Dec 2024 21:28

Repository Staff Only: item control page